Suppr超能文献

《Beers 标准》下老年心力衰竭住院患者潜在不适当用药处方分析

Prescriptions for Potentially Inappropriate Medications from the Beers Criteria Among Older Adults Hospitalized for Heart Failure.

机构信息

School of Medicine & Health Sciences, George Washington University, Washington, DC.

Department of Medicine, Weill Cornell Medicine, New York, New York.

出版信息

J Card Fail. 2022 Jun;28(6):906-915. doi: 10.1016/j.cardfail.2021.11.014. Epub 2021 Nov 21.

Abstract

BACKGROUND

We sought to better understand patterns of potentially inappropriate medications (PIMs) from the Beers criteria among older adults hospitalized with heart failure (HF). This observational study of hospitalizations was derived from the geographically diverse REasons for Geographic and Racial Differences in Stroke cohort.

METHODS AND RESULTS

We examined participants aged 65 years and older with an expert-adjudicated hospitalization for HF. The Beers criteria medications were abstracted from medical records. The prevalence of PIMs was 61.1% at admission and 64.0% at discharge. Participants were taking a median of 1 PIM (interquartile range [IQR] 0-1 PIM) at hospital admission and a median of 1 PIM (IQR 0-2 PIM) at hospital discharge. Between admission and discharge, 19.1% of patients experienced an increase in the number of PIMs, 15.1% experienced a decrease, and 37% remained on the same number between hospital admission and discharge. The medications with the greatest increase from admission to discharge were proton pump inhibitors (32.6% to 38.6%) and amiodarone (6.2% to 12.2%). The strongest determinant of potentially harmful prescribing patterns was polypharmacy (relative risk 1.34, 95% confidence interval 1.16-1.55, P < .001).

CONCLUSIONS

PIMs are common among older adults hospitalized for HF and may be an important target to improve outcomes in this vulnerable population.

摘要

背景

我们试图从 Beers 标准的角度更好地了解心力衰竭(HF)住院老年患者潜在不适当药物(PIM)的模式。这项关于住院治疗的观察性研究来源于地域多样化的 REasons for Geographic and Racial Differences in Stroke 队列。

方法和结果

我们检查了年龄在 65 岁及以上的、经专家裁决的 HF 住院患者。从病历中提取 Beers 标准药物。入院时 PIM 的患病率为 61.1%,出院时为 64.0%。入院时,患者平均服用 1 种 PIM(中位数[IQR] 0-1 PIM),出院时平均服用 1 种 PIM(中位数[IQR] 0-2 PIM)。在入院和出院期间,19.1%的患者 PIM 数量增加,15.1%的患者 PIM 数量减少,37%的患者在入院和出院期间 PIM 数量保持不变。从入院到出院,药物数量增加最多的是质子泵抑制剂(32.6%至 38.6%)和胺碘酮(6.2%至 12.2%)。潜在有害处方模式的最强决定因素是多种药物治疗(相对风险 1.34,95%置信区间 1.16-1.55,P<0.001)。

结论

PIM 在 HF 住院老年患者中很常见,可能是改善这一脆弱人群结局的重要目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48fd/9344978/204fa37b9b25/nihms-1767490-f0001.jpg

相似文献

引用本文的文献

5
Geriatric Cardiology: Coming of Age.老年心脏病学:走向成熟。
JACC Adv. 2022 Aug;1(3). doi: 10.1016/j.jacadv.2022.100070. Epub 2022 Aug 26.

本文引用的文献

2
Polypharmacy in Older Adults Hospitalized for Heart Failure.老年心力衰竭住院患者的多种药物治疗。
Circ Heart Fail. 2020 Nov;13(11):e006977. doi: 10.1161/CIRCHEARTFAILURE.120.006977. Epub 2020 Oct 13.
8
Deprescribing in Older Adults With Cardiovascular Disease.老年心血管病患者的药物减量。
J Am Coll Cardiol. 2019 May 28;73(20):2584-2595. doi: 10.1016/j.jacc.2019.03.467.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验